ProductNum | picture | CAS No. | Name and description | Size | Formula | Quick order |
---|---|---|---|---|---|---|
C60000171 |
|
25984-63-8 |
4-Hydroxythiobenzamide - 98% |
0 | C7H7NOS | |
C56964699 |
|
3770-50-1 |
Ethyl indole-2-carboxylate - 99% |
0 | C11H11NO2 | |
C56964697 |
|
936-59-4 |
3-Chloropropiophenone - 98% |
0 | C9H9ClO | |
C56964696 |
|
53100-44-0 |
BOC-L-PYR-OH - 98% |
0 | C10H15NO5 | |
C56964695 |
|
915095-84-0 |
Empagliflozin Impurity 71 - 98% |
0 | C17H14BrClO3 | |
C56964686 |
|
2296729-00-3 |
Sotorasib - 99% |
0 | C30H30F2N6O3 | |
C56964680 |
|
696-59-3 |
2,5-Dimethoxytetrahydrofuran - 98% |
0 | C6H12O3 | |
C56964673 |
|
128-37-0 |
2,6-Di-tert-butyl-4-methylphenol - 98% |
0 | C15H24O | |
C56964667 |
|
866084-31-3 |
tert-butyl 4-(6-(8-cyclopentyl-5-Methyl-7-oxo-6-(1-propoxyvinyl)-7,8-dihydropyrido[2,3-d]pyriMidin-2-ylaMino)pyridin-3-yl)piperazine-1-carboxylate - 98% |
0 | C33H45N7O4 | |
C56964660 |
|
1442472-39-0 |
Ripretinib - 99% |
0 | C24H21BrFN5O2 | |
C56964653 |
|
21739-92-4 |
5-Bromo-2-chlorobenzoic acid - 99% |
0 | C7H4BrClO2 | |
C56964631 |
|
20621-29-8 |
TRIFLUOROMETHYL SULFINYL CHLORIDE - 70% |
0 | CClF3OS | |
C56964628 |
|
1118-90-7 |
L-2-Aminoadipic acid - 98% |
0 | C6H11NO4 | |
C56964622 |
|
9007-20-9 |
Carbomer - 98% |
0 | C3H4O2 | |
C56964618 |
|
700361-47-3 |
RILPIVIRINE HCL - 98% |
0 | C22 H19 Cl N6 | |
C56964613 |
|
10343-06-3 |
2,3,4,6-Tetraacetyl-D-glucose - 98% |
0 | C14 H20 O10 | |
C56964612 |
|
10075-50-0 |
5-Bromoindole - 98% |
0 | C8H6BrN | |
C56964611 |
|
10369-83-2 |
2-Diethylaminoethyl hexanoate - 98% |
0 | C12H25NO2 | |
C56964596 |
|
1143-70-0 |
Urolithin A - 98% |
0 | C13H8O4 | |
C56964590 |
|
328086-60-8 |
Methyl (S)-2-(Boc-amino)-3-[(S)-2-oxo-3-pyrrolidinyl]propanoate - 98% |
0 | C13H22N2O5 | |